Literature DB >> 9211573

Zolpidem dependence in a patient with former polysubstance abuse.

R Bottlender1, C Schütz, H J Möller, M Soyka.   

Abstract

Zolpidem is a non-benzodiazepine hypnotic whose actions are mediated at the central GABA-A receptor complex. It has been assumed that zolpidem has a lower potential for abuse than benzodiazepines. However, there is growing evidence form clinical and animal pharmacology that the potential for dependence on zolpidem should not be underestimated (1). In human laboratory studies, abuse liability seemed to be similar to triazolam (2). Animal models suggest that the drug even had higher reinforcing properties than any benzodiazepine tested (3). In the following, a case of zolpidem abuse and dependence is described. The patient had a history of substance abuse. The observed tolerance-related events and withdrawal symptoms were comparable to those maintained by benzodiazepines.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9211573     DOI: 10.1055/s-2007-979492

Source DB:  PubMed          Journal:  Pharmacopsychiatry        ISSN: 0176-3679            Impact factor:   5.788


  4 in total

Review 1.  Evidence of zolpidem abuse and dependence: results of the French Centre for Evaluation and Information on Pharmacodependence (CEIP) network survey.

Authors:  Caroline Victorri-Vigneau; Eric Dailly; Gwenaëlle Veyrac; Pascale Jolliet
Journal:  Br J Clin Pharmacol       Date:  2007-02-23       Impact factor: 4.335

Review 2.  Zolpidem: an update of its pharmacology, therapeutic efficacy and tolerability in the treatment of insomnia.

Authors:  K J Holm; K L Goa
Journal:  Drugs       Date:  2000-04       Impact factor: 9.546

Review 3.  Sleep disorders in the elderly.

Authors:  R Asplund
Journal:  Drugs Aging       Date:  1999-02       Impact factor: 3.923

Review 4.  Drug treatment of patients with insomnia and excessive daytime sleepiness: pharmacokinetic considerations.

Authors:  S Nishino; E Mignot
Journal:  Clin Pharmacokinet       Date:  1999-10       Impact factor: 6.447

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.